General Information of the Compound
Compound ID
CP0154203
Compound Name
US9562012, mitoglitazone
    Show/Hide
Synonyms
MSDC-0160
Mitoglitazone
Mitoglitazone (TN)
    Show/Hide
Structure
Formula
C19H18N2O4S
Molecular Weight
370.43
Canonical SMILES
CCc1ccc(nc1)C(=O)COc1ccc(CC2SC(=O)NC2=O)cc1
    Show/Hide
InChI
InChI=1S/C19H18N2O4S/c1-2-12-5-8-15(20-10-12)16(22)11-25-14-6-3-13(4-7-14)9-17-18(23)21-19(24)26-17/h3-8,10,17H,2,9,11H2,1H3,(H,21,23,24)
    Show/Hide
InChIKey
IRNJSRAGRIZIHD-UHFFFAOYSA-N
CAS
146062-49-9
Physicochemical Property
logP
2.7998
Rotatable Bonds
7
Heavy Atom Count
26
Polar Areas
85.36
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10429242
SID: 15448760
ChEMBL ID
CHEMBL146624
DrugBank ID
DB11721
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00915, Peroxisome proliferator-activated receptor gamma
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL001002 GeneBLAzer UAS-bla HEK 293H Homo sapiens (Human)  1
1
EC50 = 657 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 22300 nM
Clinical Information about the Compound
Drug 1 ( Mitoglitazone )
Drug Name Mitoglitazone
Company Metabolic Solutions Development
Indication
Type-2 diabetes
Phase 2
Alzheimer disease
Phase 2
Target(s)
Insulin receptor (INSR)
Modulator